Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for prevention of emesis in autologous hematopoietic stem cell transplantation
IRCT201107026930N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of aprepitant in Vomiting, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: anti-emetic efficacy. Started May 2012; status: completed.
02
Drugs
aprepitant
03
Conditions
Vomiting
Beyond the preview
Go deeper on IRCT201107026930N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201107026930N1.